Glycoprotein IIB/IIIA antagonists
US6472405B1 · kind B1 · utility
15Cited by
4References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 1999 |
| Grant date | Oct 29, 2002 |
| Priority date | — |
| Expiry date | Apr 26, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.